Arrowpoint Asset Management »

Bridgebio Pharma shares owned by Arrowpoint Asset Management

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Arrowpoint Asset Management from 13F filings

Historical chart of Arrowpoint Asset Management investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Arrowpoint Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Arrowpoint Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.4M 110k 40.37
2023-09-30 $2.6M 110k 23.73
2019-06-30 $809k 30k 26.97

More positions owned by Arrowpoint Asset Management

Alight Com Cl A (ALIT)
Rb Global (RBA)
J Global (ZD)
Trimble Navigation (TRMB)
Cargurus Com Cl A (CARG)
Euronet Worldwide (EEFT)
Matson (MATX)
Sensata Technologies Hldg Pl SHS (ST)
Quidel Corp (QDEL)
Steris Shs Usd (STE)
Acv Auctions Com Cl A (ACVA)
Merit Medical Systems (MMSI)
Churchill Downs (CHDN)
Okta Cl A (OKTA)
Kirby Corporation (KEX)

View all positions for Arrowpoint Asset Management

Top funds holding Bridgebio Pharma

Kohlberg Kravis Roberts & Co
Viking Global Investors
Vanguard Group
Aisling Capital Management
Laurion Capital Management
Cormorant Asset Management
Goldman Sachs Group
Lord, Abbett & Co
Frazier Life Sciences Management
Alliancebernstein
Perceptive Advisors
Citigroup
Wellington Management Company
Hillhouse Capital Advisors
Norges Bank Investment Management

View all funds holding Bridgebio Pharma